RTIalert: The first respiratory tract infection (RTI) tracking program available to the public
Bayer

Contact Us Sitemap Search
Home About the RTIalert RTIalert Methodology Respiratory Season Advice Test Your Respiratory IQ About Avelox
Bayer Links




Buy Moxifloxacin (Avelox, Vigamox) eye drops and tablets online

How and where to order Avelox, Vigamox (Moxifloxacin Hydrochloride) 400 mg tablets or capsules and opthalmic solution 0.5% 5 ml online:

Shop:PHARM X SELLER - 10% discount coupon 918cc60b466a42ba
Sellers:MOXIFLOXACIN STORES
Prices:from $2.24 per pill
Forms:400 mg tablets, 0.5% 5 ml eye drops
Quantity:7-70 pills, 1-10 bottles
Type:Vigamox brand, Avelox brand and generics
Payment:Visa, Mastercard, AmEx, Cryptocurrencies
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia


Indications and usage:

Moxifloxacin (Avelox) is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below:

  • Community acquired pneumonia
  • Skin and skin structure infections: uncomplicated and complicated
  • Complicated intra-abdominal infections
  • Plague
  • Acute bacterial sinusitis
  • Acute bacterial exacerbation of chronic bronchitis

    To reduce the development of drug-resistant bacteria and maintain the effectiveness of Avelox and other antibacterial drugs. Moxifloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.


    Dosage and administration:

    The dose of Moxifloxacin (Avelox) is 400 mg every 24 hours for all types of infection:

  • Community acquired pneumonia: 7–14 days
  • Uncomplicated skin and skin structure infections (SSSI): 7 days
  • Complicated SSSI: 7–21 days
  • Complicated intra-abdominal infections: 5–14 days
  • Plague: 10–14 days
  • Acute bacterial sinusitis: 10 days
  • Acute bacterial exacerbation of chronic bronchitis: 5 days


    Dosage forms and strengt:

  • Avelox tablets: moxifloxacin hydrochloride (equivalent to 400 mg moxifloxacin).
  • Avelox injection: moxifloxacin hydrochloride (equivalent to 400 mg moxifloxacin) in 0.8% sodium chloride solution in a 250 mL flexibag.


    Contraindications:

    Known hypersensitivity to Avelox (Moxifloxacin) or other quinolones.


    Warnings and precautions:

  • Prolongation of the QT interval and isolated cases of torsade de pointes has been reported. Avoid use in patients with known prolongation, proarrhythmic conditions such as clinically significant bradycardia or acute myocardial ischemia, hypokalemia, hypomagnesemia, and with drugs that prolong the QT interval.
  • Hypersensitivity and other serious reactions: serious and sometimes fatal reactions, including anaphylactic reactions, may occur after first or subsequent doses of Avelox. Discontinue Moxifloxacin at first sign of skin rash, jaundice or any other sign of hypersensitivity.
  • Clostridium difficile-associated diarrhea: evaluate if diarrhea occurs.


    Adverse reactions, side effects:

    Most common adverse reactions of moxifloxacin ( >= 3%) were nausea, diarrhea, headache, and dizziness.

    To report suspected adverse reactions of Avelox (Moxifloxacin Hydrochloride) 400 mg, contact Bayer HealthCare Pharmaceuticals Inc. or your local FDA.


    Overdosage:

    Single oral overdoses up to 2.8 g of Moxifloxacin (Avelox) were not associated with any serious adverse events. In the event of acute overdose, empty the stomach and maintain adequate hydration. Monitor ECG due to the possibility of QT interval prolongation. Carefully observe the patient and give supportive treatment. The administration of activated charcoal as soon as possible after oral overdose may prevent excessive increase of systemic moxifloxacin exposure. About 3% and 9% of the dose of moxifloxacin, as well as about 2% and 4.5% of its glucuronide metabolite are removed by continuous ambulatory peritoneal dialysis and hemodialysis, respectively.


    Drug interactions:

  • Multivalent cation-containing products (including antacids, sucralfate, multivitamins) decreased moxifloxacin absorption. Take Avelox tablet at least 4 hours before or 8 hours after these products.
  • Warfarin: anticoagulant effect enhanced. Monitor prothrombin time/INR, and bleeding.
  • Class IA and Class III antiarrhythmics: proarrhythmic effect may be enhanced. Avoid concomitant use.
  • Antidiabetic agents: carefully monitor blood glucose.


    Use in specific populations:

  • Pregnancy: based on animal data may cause fetal harm.
  • Nursing mothers: moxifloxacin is excreted in the breast milk of rats. Because of the potential for serious adverse reactions in infants who are nursing from mothers taking this medication.
  • Pediatric use: safety and effectiveness of this medicine in pediatric patients and adolescents less than 18 years of age have not been established.
  • Geriatric use: increased risk for severe tendon disorders further increased by concomitant corticosteroid therapy and increased risk of prolongation of the QT interval.
  • Renal impairment: no dosage adjustment is necessary in patients with renal impairment, including those patients requiring hemodialysis or continuous ambulatory peritoneal dialysis.
  • Hepatic impairment: no dosage adjustment is recommended for mild, moderate, or severe hepatic insufficiency.


    Where to buy moxifloxacin online:

    To purchase Vigamox, Avelox (Moxifloxacin Hydrochloride) 400 mg pills and opthalmic solution 0.5% 5 ml from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.


    Here is a list of popular medications containing moxifloxacin hydrochloride as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    Avelox
  • Injectable; Infusion; 400 mg / 250 ml
  • Tablets, Film-Coated; Oral; 400 mg
  • Bayer
  • B & S Healthcare
  • BayHealth Comercializacao de Produtos Farmaceuticos
  • Fresenius
  • Gen Medicine
  • Maxxcare
  • Merck
  • Moxicip
  • Drops; Ophthalmic; 0.5%
  • Injectable; Infusion; 400 mg / 250 ml, 400 mg / 100 ml
  • Ointment; Ophthalmic; 0.5%
  • Tablets, Film-Coated; Oral; 400 mg
  • Cipla
  • Moxif
  • Injectable; Infusion; 400 mg / 100 ml
  • Tablets; Oral; 400 mg
  • Torrent Pharmaceuticals
  • Vigamox
  • Solution; Ophthalmic; 0.5%
  • Alcon
  • Alkem Pharmaceuticals
  • Medcor Pharmaceuticals
  • Novartis






  • Copyright © 2001 - 2024 Respiratory Tract Infection Alert System by Bayer Corporation. All rights reserved.